S. Goodin

发表

Lapatinib: a dual inhibitor of human epidermal growth factor receptor tyrosine kinases.

Susan Goodin, P. Medina, S. Goodin, 2008, Clinical Therapeutics.

Epothilones: mechanism of action and biologic activity.

E. Rubin, S. Goodin, M. Kane, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Full costs of dispensing and administering fluorouracil chemotherapy for outpatients: A microcosting study.

D. Suh, J. Barone, S. Goodin, 2010, Research in social & administrative pharmacy : RSAP.

The Effects and Mechanism of YK-4-279 in Combination with Docetaxel on Prostate Cancer

Xi Zheng, Dongli Li, Xiaofeng Wu, 2017, International journal of medical sciences.

In vitro activation of irinotecan to SN-38 by human liver and intestine.

T. Ravikumar, E. Rubin, E. Gupta, 1999, Anticancer research.

Transdermal estradiol in castrate and chemotherapy resistant prostate cancer

S. Doyle-Lindrud, R. DiPaola, W. Shih, 2012, Medical science monitor : international medical journal of experimental and clinical research.

Brefeldin A enhances docetaxel-induced growth inhibition and apoptosis in prostate cancer cells in monolayer and 3D cultures.

Xi Zheng, Dongli Li, Xiaofeng Wu, 2017, Bioorganic & medicinal chemistry letters.

NSAIDs for the Chemoprevention of Oral Cancer: Promise or Pessimism?

S. Shiff, S. Goodin, 2004, Clinical Cancer Research.

Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival

S. Goodin, J. Nishioka, 2007, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Mechanistic Study of Inhibitory Effects of Metformin and Atorvastatin in Combination on Prostate Cancer Cells in Vitro and in Vivo.

Xi Zheng, Dongli Li, Huarong Huang, 2017, Biological & pharmaceutical bulletin.

Cancer-treatment-induced bone loss, part 2.

S. Goodin, L. Michaud, 2006, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

State-of-the-art treatment of metastatic hormone-refractory prostate cancer.

R. DiPaola, S. Goodin, Kamakshi V. Rao, 2002, The oncologist.

Treatment of hormone-refractory prostate cancer

R. DiPaola, P. Medina, S. Goodin, 1999 .

Plasma, Prostate and Urine Levels of Tocopherols and Metabolites in Men after Supplementation with a γ-Tocopherol-Rich Vitamin E Mixture

M. Orlick, W. Shih, Xi Zheng, 2020, Nutrition and cancer.

Development of monoclonal antibodies for the treatment of colorectal cancer.

S. Goodin, 2008, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Which role shall the pharmacists play in oncology 3 Cover Story Oral Chemotherapeutic Agents Safe handling of oral chemotherapeutic agents : 4 a European perspective

N. Griffith, S. Goodin, K. Meier, 2011 .

Novel cytotoxic agents: epothilones.

S. Goodin, 2008, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Conceptualization of disease timeline predicts posttreatment distress in breast cancer patients.

Carolyn Rabin, H. Leventhal, S. Goodin, 2004, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

5-HT(3)-receptor antagonists for the treatment of nausea and vomiting: a reappraisal of their side-effect profile.

S. Goodin, R. Cunningham, 2002, The oncologist.

A phase I study of AT-101, a BH3 mimetic, in combination with paclitaxel and carboplatin in solid tumors

A. Tan, N. Ready, M. Stein, 2019, Investigational New Drugs.

Basic Bibliographies

S. Goodin, 2000 .

A validated bioanalytical HPLC method for pharmacokinetic evaluation of 2-deoxyglucose in human plasma.

R. DiPaola, J. Bertino, A. Kong, 2012, Biomedical chromatography : BMC.

Antiemetic care for patients with breast cancer: focus on drug interactions and safety concerns.

S. Goodin, A. Georgy, J. Neceskas, 2007, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Strategies for using cytoprotective agents to improve outcomes associated with cancer chemotherapy

R. DiPaola, S. Goodin, 1998 .

Abiraterone in Prostate Cancer: A New Angle to an Old Problem

R. DiPaola, M. Stein, S. Goodin, 2012, Clinical Cancer Research.

Selecting an anticoagulant for recurrent venous thromboembolism in cancer.

S. Goodin, 2005, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Potent Inhibitory Effect of δ-Tocopherol on Prostate Cancer Cells Cultured in Vitro and Grown As Xenograft Tumors in Vivo

Hong Wang, R. DiPaola, A. Conney, 2014, Journal of agricultural and food chemistry.

Potent inhibitory effect of terpenoids from Acanthopanax trifoliatus on growth of PC-3 prostate cancer cells in vitro and in vivo is associated with suppression of NF-κB and STAT3 signalling

Xi Zheng, Dongli Li, Huarong Huang, 2015 .

Effect of docetaxel in patients with hormone-dependent prostate-specific antigen progression after local therapy for prostate cancer.

S. Doyle-Lindrud, R. DiPaola, W. Shih, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I trial of weekly paclitaxel, 13-cis-retinoic acid, and interferon alpha in patients with prostate cancer and other advanced malignancies

S. Doyle-Lindrud, R. DiPaola, D. Dvorzhinski, 2003, Cancer Chemotherapy and Pharmacology.

Inhibitory Effect of a γ-Tocopherol-Rich Mixture of Tocopherols on the Formation and Growth of LNCaP Prostate Tumors in Immunodeficient Mice

R. DiPaola, Ying Huang, A. Kong, 2011, Cancers.

Combined effects of atorvastatin and aspirin on growth and apoptosis in human prostate cancer cells.

Xi Zheng, Dongli Li, Huarong Huang, 2017, Oncology reports.

Clinical and Biologic Activity of an Estrogenic Herbal Combination (PC-SPES) in Prostate Cancer

R. DiPaola, M. Gallo, M. Toledano, 1998 .

Ixabepilone: a novel microtubule-stabilizing agent for the treatment of metastatic breast cancer.

S. Goodin, 2008, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Oral chemotherapeutic agents: understanding mechanisms of action and drug interactions.

S. Goodin, 2007, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Pharmacists' critical role in cancer clinical trials.

S. Goodin, 2018, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer.

R. DiPaola, M. Gallo, M. Toledano, 1999, The New England journal of medicine.

Prevention of Delayed Chemotherapy-Induced Nausea and Vomiting After Moderately High to Highly Emetogenic Chemotherapy: Comparison of Ondansetron, Prochlorperazine, and Dexamethasone

M. Socinski, M. Schell, C. Lindley, 2005, American journal of clinical oncology.

Estimation of creatinine clearance in patients with gynecologic cancer.

W. Leader, M. Chandler, S. Goodin, 1993, Clinical pharmacy.

RICE UNIVERSITY NAGEL'S THEORY OF THE SUBJECTIVE AND OBJECTIVE: IMPLICATIONS FOR RATIONALITY IN ETHICS by SUSANNA LEE GOODIN A THESIS SUBMITTED IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE MASTER OF ARTS

Larry S. Temkin, D. Parfit, B. Brody, 2018 .

Essential Oils from Zingiber striolatum Diels Attenuate Inflammatory Response and Oxidative Stress through Regulation of MAPK and NF-κB Signaling Pathways

Xuetong Li, Xi Zheng, Kun Zhang, 2021, Antioxidants.

An Analysis of U.S. Disinvestment from South Africa: Unity, Rights, and Justice

S. Goodin, D. Malone, 1997 .

ASHP guidelines on preventing medication errors with chemotherapy and biotherapy.

J. Hoffman, N. Griffith, S. Goodin, 2015, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Tubulin-targeting agents.

W. Hait, E. Rubin, S. Goodin, 2007, Cancer chemotherapy and biological response modifiers.

Chemotherapy for metastatic melanoma during pregnancy.

T. Ravikumar, R. DiPaola, S. Goodin, 1997, Gynecologic oncology.

Drug-drug interactions in oncology: why are they important and can they be minimized?

M. Aapro, R. de Wit, S. Goodin, 2005, Critical reviews in oncology/hematology.

Phase I clinical and pharmacologic study of 13-cis-retinoic acid, interferon alfa, and paclitaxel in patients with prostate cancer and other advanced malignancies.

R. DiPaola, W. Hait, D. Toppmeyer, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase I trial of 5-day continuous infusion cisplatin and interferon α

R. Yokel, S. Goodin, M. Gosland, 2004, Cancer Chemotherapy and Pharmacology.

Combination of α-Tomatine and Curcumin Inhibits Growth and Induces Apoptosis in Human Prostate Cancer Cells

Y. Li, R. DiPaola, Xi Zheng, 2015, PloS one.

α-tomatine inhibits growth and induces apoptosis in HL-60 human myeloid leukemia cells

A. Conney, Xi Zheng, Dongli Li, 2015, Molecular medicine reports.

Combination of diethyldithiocarbamate with 12-O-tetradecanoyl phorbol-13-acetate inhibits the growth of human myeloid leukemia HL-60 cells in vitro and in xenograft model

Xi Zheng, Dongli Li, Huarong Huang, 2020, Bioscience, biotechnology, and biochemistry.

Mechanistic Study of Inhibitory Effects of Atorvastatin and Docetaxel in Combination on Prostate Cancer.

Jian Wu, Xi Zheng, Huarong Huang, 2016, Cancer genomics & proteomics.

Targeting tumor metabolism with 2‐deoxyglucose in patients with castrate‐resistant prostate cancer and advanced malignancies

Kevin Bray, Eileen White, E. White, 2010, The Prostate.

Atorvastatin and Caffeine in Combination Regulates Apoptosis, Migration, Invasion and Tumorspheres of Prostate Cancer Cells

Xi Zheng, Hongping Xiang, Xiaofeng Wu, 2018, Pathology & Oncology Research.

Combination of Lipitor and Celebrex inhibits prostate cancer VCaP cells in vitro and in vivo.

Hong Wang, R. DiPaola, A. Conney, 2014, Anticancer research.

Effects of atorvastatin in combination with celecoxib and tipifarnib on proliferation and apoptosis in pancreatic cancer sphere-forming cells.

Xiang Ren, Xi Zheng, Dongli Li, 2020, European journal of pharmacology.

Pharmacokinetics and Pharmacodynamics of Zoledronic Acid in Cancer Patients with Bone Metastases

P. LoRusso, H. Schran, J. Berenson, 2002, Journal of clinical pharmacology.

Tubulin targeting agents.

W. Hait, E. Rubin, S. Goodin, 2001, Cancer chemotherapy and biological response modifiers.

Inhibitory effect of roburic acid in combination with docetaxel on human prostate cancer cells

Xi Zheng, Dongli Li, Kun Zhang, 2022, Journal of enzyme inhibition and medicinal chemistry.

The Mangrove-Derived Diterpenoid Diaporthe B Inhibits the Stemness and Increases the Efficacy of Docetaxel in Prostate Cancer PC-3 Cells

Xi Zheng, Huarong Huang, Kun Zhang, 2021, Natural Product Communications.

Ixabepilone, a New Treatment Option for Metastatic Breast Cancer

D. Toppmeyer, S. Goodin, 2010, American journal of clinical oncology.

Overcoming Drug Resistance in Patients with Metastatic Breast Cancer

S. Goodin, S. Wong, 2009, Pharmacotherapy.

17/3-Estradiol Glucuronide: An Inducer of Cholestasis and a Physiological Substrate for the Multidrug Resistance Transporter1

Michael, M. Vore, S. Goodin, 2006 .

17 beta-estradiol glucuronide: an inducer of cholestasis and a physiological substrate for the multidrug resistance transporter.

M. Vore, S. Goodin, M. Gosland, 1993, Cancer research.

A phase I trial of MK-2206 and hydroxychloroquine in patients with advanced solid tumors

E. White, A. Tan, J. Bertino, 2019, Cancer Chemotherapy and Pharmacology.

Comparison of LC-MS Assay and HPLC Assay of Busulfan in Clinical Pharmacokinetics Studies

R. DiPaola, R. Strair, M. Gounder, 2012 .

Effect of 13-cis-retinoic acid and α-interferon on transforming growth factor in patients with rising prostate-specific antigen

R. DiPaola, M. Anscher, Z. Rasheed, 1997 .

Pharmacokinetics of Cetuximab After Administration of Escalating Single Dosing and Weekly Fixed Dosing in Patients with Solid Tumors

M. Hidalgo, J. Doroshow, A. Tan, 2006, Clinical Cancer Research.

Effect of P-30 protein and tamoxifen on transforming growth factor-β1 in patients with rising prostate specific antigen

R. DiPaola, R. Weiss, K. Cummings, 2001 .

Nobiletin, a citrus polymethoxyflavone, enhances the effects of bicalutamide on prostate cancer cells via down regulation of NF-κB, STAT3, and ERK activation

Xi Zheng, Dongli Li, S. Goodin, 2020, RSC advances.

Safe handling of oral chemotherapeutic agents in clinical practice: recommendations from an international pharmacy panel.

C. Doreau, N. Griffith, S. Goodin, 2011, Journal of oncology practice.

Tubulin-targeting agents.

W. Hait, E. Rubin, S. Goodin, 2003, Cancer chemotherapy and biological response modifiers.

Phase I trial of weekly docetaxel with concurrent three-dimensional conformal radiation therapy in the treatment of unfavorable localized adenocarcinoma of the prostate.

R. DiPaola, R. Weiss, K. Cummings, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase II trial of imatinib mesylate in patients with prostate specific antigen progression after local therapy for prostate cancer

S. Doyle-Lindrud, R. DiPaola, W. Shih, 2005, The Prostate.

(3E,5E)-3,5-Bis(pyridin-3-methylene)-tetrahydrothiopyran-4-one enhances the inhibitory effect of gemcitabine on pancreatic cancer cells.

Xi Zheng, Dongli Li, Kun Zhang, 2020, Bioorganic chemistry.

Management of Venous Thromboembolism and the Potential to Impact Overall Survival in Patients with Cancer

S. Goodin, B. Saraiya, 2009, Pharmacotherapy.

Erlotinib: Optimizing Therapy with Predictors of Response?

S. Goodin, 2006, Clinical Cancer Research.

Comparative Effects of Two Different Forms of Selenium on Oxidative Stress Biomarkers in Healthy Men: A Randomized Clinical Trial

R. DiPaola, M. Kaag, T. Hartman, 2014, Cancer Prevention Research.

A phase II trial of docetaxel and vinorelbine in patients with hormone-refractory prostate cancer

S. Doyle-Lindrud, R. DiPaola, S. Goodin, 2005, Cancer Chemotherapy and Pharmacology.

Safety and tolerability of eribulin mesylate in patients with pretreated metastatic breast cancer.

S. Goodin, James X. Song, S. Barbour, 2015, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Eriocitrin in combination with resveratrol ameliorates LPS-induced inflammation in RAW264.7 cells and relieves TPA-induced mouse ear edema

Xi Zheng, Dongli Li, Huarong Huang, 2019, Journal of Functional Foods.

Clinical and Biological Activity of Soy Protein Powder Supplementation in Healthy Male Volunteers

R. DiPaola, M. Gallo, W. Shih, 2007, Cancer Epidemiology Biomarkers & Prevention.

Phenethyl isothiocyanate in combination with dibenzoylmethane inhibits the androgen-independent growth of prostate cancer cells.

Xi Zheng, Dongli Li, Hongping Xiang, 2018, Food & function.

Effects and mechanism of inhibition of naringin in combination with atorvastatin on prostate cancer cells in vitro and in vivo

Xi Zheng, Dongli Li, Xiaofeng Wu, 2019, Phytochemistry Letters.

A Phase II Study of AT-101 to Overcome Bcl-2--Mediated Resistance to Androgen Deprivation Therapy in Patients With Newly Diagnosed Castration-Sensitive Metastatic Prostate Cancer.

R. DiPaola, W. Stadler, M. Hussain, 2016, Clinical Genitourinary Cancer.

Cancer-treatment-induced bone loss, part 1.

S. Goodin, L. Michaud, 2006, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Inhibition of IL-6 expression in LNCaP prostate cancer cells by a combination of atorvastatin and celecoxib

R. DiPaola, A. Conney, Xi Zheng, 2013, Oncology reports.

A phase I trial of riluzole and sorafenib in patients with advanced solid tumors: CTEP #8850

S. Ganesan, W. Shih, Suzie Chen, 2023, Oncotarget.

Nobiletin Inhibits Cell Growth, Migration and Invasion, and Enhances the Anti-Cancer Effect of Gemcitabine on Pancreatic Cancer Cells

Xiang Ren, Xi Zheng, Dongli Li, 2021, Natural Product Communications.

Celecoxib combined with salirasib strongly inhibits pancreatic cancer cells in 2D and 3D cultures

Xi Zheng, Dongli Li, Kun Zhang, 2020, International journal of medical sciences.

Phase I study of at-101 (R-(-)-gossypol) in combination with paclitaxel (P) and carboplatin (C) in solid tumors including castrate-resistant prostate cancer (CRPC).

A. Tan, M. Stein, R. Moss, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

In Reply: Evidence for Equivalent Cardiotoxicity of the 5-HT3 Receptor Antagonists

S. Goodin, R. Cunningham, 2003 .